Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Filtros aplicados
  • País/Região como assunto

Intervalo de ano de publicação
1.
Int J Antimicrob Agents ; : 106037, 2020 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-32479893

RESUMO

For decades, Ivermectin (IVM) has been recognized as a robust antiparasitic drug with excellent tolerance and safety profiles. Historically it has been used as the drug of choice for onchocerciasis and lymphatic filariasis global elimination programs. IVM is also a standard treatment against intestinal helminths and ectoparasites given its action as an oral insecticide. The current humanitarian crisis in Venezuela is a regional public health threat that requires immediate action. Venezuela's public health system has now crumbled due to a 70% shortage of medicines in public hospitals, low vaccination campaigns, and the massive exodus of medical personnel. Herein we discuss the repurposing of IVM to attenuate the burden imposed by the most prevalent neglected tropical diseases (NTDs) in Venezuela including soil-transmitted helminths, ectoparasites and, possibly, vector-borne diseases such as malaria. Additionally, novel experimental evidence has shown that IVM is active and efficacious against Chagas disease, Leishmaniases, arboviruses, and SARS-CoV-2 in vitro. In crisis-hit Venezuela, all of the aforementioned infectious diseases are public health emergencies that have been long ignored and that also require immediate attention. IVM's versatile nature could serve as a powerful tool to tackle the multiple overlapping endemic and emergent diseases that affect Venezuela today. The repurposing of this multipurpose drug would be without a doubt a timely therapeutical approach to help mitigate the tremendous burden of NTDs nationwide.

5.
Caracas; Ministerio del Poder Popular para la Salud; 24/04/2020. 14 p.
Não convencional em Espanhol | LILACS, LIVECS | ID: biblio-1100746

RESUMO

Los lineamientos se enmarcan en la mejor evidencia científica y las recomendaciones disponibles hasta la fecha. Los presentes lineamientos son provisorios y se actualizarán en la medida en que surjan nuevas evidencias, recomendaciones o buenas prácticas. Tome en cuenta que la pandemia por COVID-19 es una situación que está en evolución (AU)


Assuntos
Pneumonia Viral/prevenção & controle , Saúde Materno-Infantil , Infecções por Coronavirus/prevenção & controle , Pandemias/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA